GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma

PLoS Genetics

Volumn 7, Issue 4, 2011, Pages

  Smedby, Karin E ^a   Foo, Jia Nee ^b   Skibola, Christine F ^c   Darabi, Hatef ^a   Conde, Lucia ^c   Hjalgrim, Henrik ^d   Kumar, Vikrant ^b   Chang, Ellen T ^e,f   Rothman, Nathaniel ^g   Cerhan, James R ^h   Brooks Wilson, Angela R ^i,j   Rehnberg, Emil ^a   Irwan, Ishak D ^b   Ryder, Lars P ^k   Brown, Peter N ^k   Bracci, Paige M ^l   Agana, Luz ^c   Riby, Jacques ^c   Cozen, Wendy ^m   Davis, Scott ^n,o   Hartge, Patricia ^g   Morton, Lindsay M ^g   Severson, Richard K ^p,q   Wang, Sophia S ^g,r   Slager, Susan L ^h   Fredericksen, Zachary S ^h   Novak, Anne J ^h   Kay, Neil E ^h   Habermann, Thomas M ^h   Armstrong, Bruce ^s   Kricker, Anne ^s   Milliken, Sam ^t   Purdue, Mark P ^g   Vajdic, Claire M ^u   Boyle, Peter ^v   Lan, Qing ^g   Zahm, Shelia H ^g   Zhang, Yawei ^w   Zheng, Tongzhang ^w   Leach, Stephen ^x   Spinelli, John J ^i,y   Smith, Martyn T ^c   Chanock, Stephen J ^g   Padyukov, Leonid ^z   Alfredsson, Lars ^a   Klareskog, Lars ^z   Glimelius, Bengt ^a,aa   Melbye, Mads ^d   Liu, Edison T ^b   Adami, Hans Olov ^a,ab   Humphreys, Keith ^a   Liu, Jianjun ^b   more..

^a KAROLINSKA INSTITUTE   (Sweden)

^b GENOME INSTITUTE OF SINGAPORE   (Singapore)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d STATENS SERUM INSTITUT   (Denmark)

^e CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g NATIONAL CANCER INSTITUTE   (United States)

^h MAYO CLINIC   (United States)

ⁱ BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^j SIMON FRASER UNIVERSITY   (Canada)

^k Mental Health Services CPH   (Denmark)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁿ Fred Hutchinson Cancer Research Center   (United States)

^o UNIVERSITY OF WASHINGTON   (United States)

^p WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^q KARMANOS CANCER INSTITUTE   (United States)

^r CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^s UNIVERSITY OF SYDNEY   (Australia)

^t ST VINCENT S HOSPITAL   (Australia)

^u UNIVERSITY OF NEW SOUTH WALES   (Australia)

^v INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

^w YALE UNIVERSITY   (United States)

^x BRITISH COLUMBIA CANCER AGENCY   (Canada)

^y UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^z KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^aa UPPSALA UNIVERSITY   (Sweden)

^ab HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2;

ARTICLE; CHROMOSOME 6P; CONTROLLED STUDY; FOLLICULAR LYMPHOMA; FOLLOW UP; GENE LOCUS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MARGINAL ZONE LYMPHOMA; NONHODGKIN LYMPHOMA; SINGLE NUCLEOTIDE POLYMORPHISM; CHROMOSOME 6; DENMARK; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENETICS; HUMAN GENOME; RISK FACTOR; SWEDEN;

CHROMOSOMES, HUMAN, PAIR 6; DENMARK; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE B-CELL, DIFFUSE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SWEDEN;

EID: 79955574316     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1001378     Document Type: Article

References (31)

1. Jaffe ES, Harris NL, Stein H, Vardiman J, (2001) World Health Organization classification of tumours pathology and genetics, tumours of hematopoietic and lymphoid tissues. Lyon IARC Press.
2. Morton LM, Wang SS, Cozen W, Linet MS, Chatterjee N, et al. (2008) Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood 112: 5150-5160.
3. Altieri A, Bermejo JL, Hemminki K, (2005) Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database. Blood 106: 668-672.
4. Chang ET, Smedby KE, Hjalgrim H, Glimelius B, Adami HO, (2006) Reliability of self-reported family history of cancer in a large case-control study of lymphoma. J Natl Cancer Inst 98: 61-68.
5. Skibola CF, Bracci PM, Halperin E, Conde L, Craig DW, et al. (2009) Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma. Nat Genet 41: 873-875.
6. Conde L, Halperin E, Brown KM, Smedby KE, Rothman N, et al. (2010) Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet 42: 661-664.
7. de Bakker PI, Ferreira MA, Jia X, Neale BM, Raychaudhuri S, et al. (2008) Practical aspects of imputation-driven meta-analysis of genome-wide association studies. Hum Mol Genet 17: R122-128.
8. Cerhan JR, Ansell SM, Fredericksen ZS, Kay NE, Liebow M, et al. (2007) Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma. Blood 110: 4455-4463.
9. Wang SS, Cerhan JR, Hartge P, Davis S, Cozen W, et al. (2006) Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma. Cancer Res 66: 9771-9780.
10. Zhang Y, Holford TR, Leaderer B, Boyle P, Zahm SH, et al. (2004) Hair-coloring product use and risk of non-Hodgkin's lymphoma: a population-based case-control study in Connecticut. Am J Epidemiol 159: 148-154.
11. Hughes AM, Armstrong BK, Vajdic CM, Turner J, Grulich A, et al. (2004) Pigmentary characteristics, sun sensitivity and non-Hodgkin lymphoma. Int J Cancer 110: 429-434.
12. Spinelli JJ, Ng CH, Weber JP, Connors JM, Gascoyne RD, et al. (2007) Organochlorines and risk of non-Hodgkin lymphoma. Int J Cancer 121: 2767-2775.
13. Song YS, Hein J, (2005) Constructing minimal ancestral recombination graphs. J Comput Biol 12: 147-169.
14. Bandelt HJ, Forster P, Rohl A, (1999) Median-joining networks for inferring intraspecific phylogenies. Mol Biol Evol 16: 37-48.
15. de Bakker PI, McVean G, Sabeti PC, Miretti MM, Green T, et al. (2006) A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet 38: 1166-1172.
16. Leslie S, Donnelly P, McVean G, (2008) A statistical method for predicting classical HLA alleles from SNP data. Am J Hum Genet 82: 48-56.
17. Wang SS, Abdou AM, Morton LM, Thomas R, Cerhan JR, et al. (2010) Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology. Blood 115: 4820-4823.
18. Abdou AM, Gao X, Cozen W, Cerhan JR, Rothman N, et al. (2010) Human leukocyte antigen (HLA) A1-B8-DR3 (8.1) haplotype, tumor necrosis factor (TNF) G-308A, and risk of non-Hodgkin lymphoma. Leukemia 24: 1055-1058.
19. Bateman AC, Howell WM, (1999) Human leukocyte antigens and cancer: is it in our genes? J Pathol 188: 231-236.
20. Dixon AL, Liang L, Moffatt MF, Chen W, Heath S, et al. (2007) A genome-wide association study of global gene expression. Nat Genet 39: 1202-1207.
21. Plenge RM, Seielstad M, Padyukov L, Lee AT, Remmers EF, et al. (2007) TRAF1-C5 as a risk locus for rheumatoid arthritis-a genomewide study. N Engl J Med 357: 1199-1209.
22. Baecklund E, Backlin C, Iliadou A, Granath F, Ekbom A, et al. (2006) Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis. Arthritis Rheum 54: 3774-3781.
23. Rothman N, Skibola CF, Wang SS, Morgan G, Lan Q, et al. (2006) Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol 7: 27-38.
24. Skibola CF, Bracci PM, Nieters A, Brooks-Wilson A, de Sanjose S, et al. (2010) Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol 171: 267-276.
25. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, et al. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403: 503-511.
26. Smedby KE, Hjalgrim H, Melbye M, Torrang A, Rostgaard K, et al. (2005) Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst 97: 199-209.
27. Plenge RM, Padyukov L, Remmers EF, Purcell S, Lee AT, et al. (2005) Replication of putative candidate-gene associations with rheumatoid arthritis in &4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet 77: 1044-1060.
28. Magnusson C, Baron J, Persson I, Wolk A, Bergstrom R, et al. (1998) Body size in different periods of life and breast cancer risk in post-menopausal women. Int J Cancer 76: 29-34.
29. Price AL, Weale ME, Patterson N, Myers SR, Need AC, et al. (2008) Long-range LD can confound genome scans in admixed populations. Am J Hum Genet 83: 132-135; author reply 135-139.
30. Stephens M, Smith NJ, Donnelly P, (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68: 978-989.
31. Lyngsø R, Song Y, Hein J, (2005) Minimum recombination histories by branch and bound, proceedings of workshop on algorithms in bioinformatics. Lect Notes Comput Sci 3692: 239-250.